Favorable early safety and initial efficacy data from BEST1 program highlighted at premier gathering of global retinal experts with additional ...

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to the brain.

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to the brain. During development, all the specialized neurons in the ...

Good morning, and welcome to Ocugen's Fourth Quarter and Full Year 2025 Financial Results and Business Update [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head ...

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

Enrollment for the OCU400 Phase 3 liMeliGhT clinical trial—the first and largest gene therapy registrational trial for broad retinitis pigmentosa ...

After three months, OPGx-BEST1 was well tolerated with no reports of observed ocular inflammation or adverse events.

Cigarette smoke accelerates eye aging by causing epigenetic changes that block the eye's natural repair genes.

Through a series of experiments supported by the National Institutes of Health, Johns Hopkins Medicine (JHM) researchers say ...

Hopkins researchers identify how smoking, a well-known risk factor for eye disease and vision loss, increases susceptibility to age-related eye disease ...

A freshwater snail can regrow its entire eye, rebuilding the lens, retina, and optic nerve in about a month. Because its eyes share key genes and structures with ours, scientists are using CRISPR to ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a doctor’s office. Ikarovec’s IKAR-003 is currently in preclinical ...